E. Schrumpf

8.3k total citations · 1 hit paper
154 papers, 4.0k citations indexed

About

E. Schrumpf is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, E. Schrumpf has authored 154 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Surgery, 60 papers in Hepatology and 56 papers in Epidemiology. Recurrent topics in E. Schrumpf's work include Liver Diseases and Immunity (45 papers), Liver Disease Diagnosis and Treatment (33 papers) and Helicobacter pylori-related gastroenterology studies (32 papers). E. Schrumpf is often cited by papers focused on Liver Diseases and Immunity (45 papers), Liver Disease Diagnosis and Treatment (33 papers) and Helicobacter pylori-related gastroenterology studies (32 papers). E. Schrumpf collaborates with scholars based in Norway, Sweden and Denmark. E. Schrumpf's co-authors include O. Fausa, K. Elgjo, Kirsten Muri Boberg, E Gjone, F. Kolmannskog, L. E. Hanssen, J. Myren, S Ritland, Erik Thorsby and A. Bergan and has published in prestigious journals such as The Lancet, Nature Biotechnology and Hepatology.

In The Last Decade

E. Schrumpf

150 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation

2015 285 citations Fotios Sampaziotis, Miguel Cardoso de Brito et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by E. Schrumpf

Since Specialization

Citations

This map shows the geographic impact of E. Schrumpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schrumpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schrumpf more than expected).

Fields of papers citing papers by E. Schrumpf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schrumpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schrumpf. The network helps show where E. Schrumpf may publish in the future.

Co-authorship network of co-authors of E. Schrumpf

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schrumpf. A scholar is included among the top collaborators of E. Schrumpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schrumpf. E. Schrumpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation breakdown → 2015 ·Nature Biotechnology ·Fotios Sampaziotis, Miguel Cardoso de Brito, Pedro Madrigal, Alessandro Bertero, Kourosh Saeb‐Parsy, Filipa Soares, E. Schrumpf, Espen Melum, Tom H. Karlsen, J. A. Bradley, William Gelson, Susan Davies, Alastair Baker, Arthur Kaser, Graeme Alexander, Nicholas R. F. Hannan, Ludovic Vallier	285
2	22 ELECTROSTATIC MODIFICATIONS OF THE HLA-DR P9 PEPTIDE-BINDING POCKET AND SUSCEPTIBILITY TO PRIMARY SCLEROSING CHOLANGITIS 2011 ·Journal of Hepatology ·Johannes R. Hov, Vasilis Kosmoliaptsis, (unknown), Marita Olsson, K.M. Boberg, Annika Bergquist, E. Schrumpf, J. Andrew Bradley, Clare Taylor, Benedicte A. Lie, John Trowsdale, (unknown)	5
3	ASSESSMENT OF 479 PATIENTS WITH AUTOIMMUNE LIVER DISEASES ACCORDING TO THE IAIHG SCORING SYSTEM FOR AUTOIMMUNE HEPATITIS DOES NOT SUPPORT THE CONTENTION OF OVERLAP SYNDROMES AS SEPARATE DIAGNOSTIC ENTITIES 2009 ·Hepatology ·K.M. Boberg, AW Lohse, Elke Hennes, H. P. Dienes, E. Jenny Heathcote, Roger W. Chapman, E. Schrumpf	6
4	Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis 2007 ·Genes and Immunity ·Tom H. Karlsen, Kirsten Muri Boberg, Morten Vatn, (unknown), Annika Bergquist, Jochen Hampe, E. Schrumpf, Erik Thorsby, Stefan Schreiber, Benedicte A. Lie	44
5	ABO‐incompatible deceased donor liver transplantation with the use of antigen‐specific immunoadsorption and anti‐CD20 monoclonal antibody 2006 ·Clinical Transplantation ·Kirsten Muri Boberg, A. Foss, Karsten Midtvedt, E. Schrumpf	17
6	Hepatic and extrahepatic malignancies and primary sclerosing cholangitis 2003 ·Gut ·E. Schrumpf, (unknown)	8
7	Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis 2001 ·Gut ·S.A. Mitchell, Jane I. Grove, Anne Spurkland, Kirsten Muri Boberg, K A Fleming, Christopher P. Day, E. Schrumpf, R Chapman, (unknown)	79
8	HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups. 1998 ·Hepatology ·S. Saarinen, K.M. Boberg, Anne Spurkland, (unknown), Ulrika Broomé, F. Rosina, R Chapman, Albert Parés, Olle Olerup, E. Schrumpf	1
9	Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model. 1998 ·Hepatology ·K.M. Boberg, Giorgia Della Rocca, Anne Spurkland, Ulrika Broomé, R. Chapman, Stephen Mitchell, Albert Parés, F. Rosina, E. Schrumpf	1
10	Two Dose Regimens of Recombinant Interferon-Alpha-2b in Chronic Hepatitis C Virus Infection: Biochemistry, Hepatitis C Virus RNA, and Liver Histology as Response Indices 1995 ·Scandinavian Journal of Gastroenterology ·Kristian Bjøro, Henrik Krarup, H. Bell, Palle Christophersen, Stein A. Evensen, Stig S. Frøland, Alex Lund Laursen, Bent von der Lippe, A Mæland, L Ranek, Helmer Ring‐Larsen, Geert Schou, E. Schrumpf, Niels Tygstrup	10
11	Hepatic Retention of Copper and Selenium in Primary Sclerosing Cholangitis 1995 ·Scandinavian Journal of Gastroenterology ·Jan Aaseth, Yngvar Thomassen, E. Aadland, O. Fausa, E. Schrumpf	8
12	Side Effects and Complications after Hepatic Artery Embolization in the Carcinoid Syndrome 1991 ·Scandinavian Journal of Gastroenterology ·F. Kolmannskog, A Kolbenstvedt, E. Schrumpf, L. E. Hanssen	17
13	Effect of Misoprostol and Antacids on Gastric and Duodenal Mucosal Enzyme Activities in Duodenal Ulcer Patients 1991 ·Scandinavian Journal of Gastroenterology ·(unknown), E. Schrumpf, Knut-Jan Andersen, Dankert W. Skagen, Ole J. Halvorsen	2
14	Hepatic Lesions in Adult Coeliac Disease 1990 ·Scandinavian Journal of Gastroenterology ·M. B. Jacobsen, O. Fausa, K. Elgjo, E. Schrumpf	87
15	Epidemiology of Crohn's Disease in Western Norway 1989 ·Scandinavian Journal of Gastroenterology ·Kjell Haug, E. Schrumpf, Jan F. Halvorsen, G Fluge, (unknown), (unknown), (unknown)	49
16	Medical and endoscopical treatment of esophageal varices that have bled a review 1987 ·Scandinavian Journal of Gastroenterology ·E. Schrumpf	1
17	Primary Sclerosing Cholangitis: A Long-Term Follow-up Study 1987 ·Scandinavian Journal of Gastroenterology ·E. Aadland, E. Schrumpf, O. Fausa, K. Elgjo, Arne Heilo, T Aakhus, E Gjone	216
18	The effect of TRIMIPRAMINE (Surmontil) on the stimulated gastric secretion and serum gastrin concentration in healthy students. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Thomas M. Bohman, E. Schrumpf, J. Myren, Olav Foss	5
19	Effect of Atropine on Insulin-Stimulated Gastrin Release and Gastric Secretion of Acid, Pepsin, and Intrinsic Factor (IF) 1974 ·Scandinavian Journal of Gastroenterology ·E. Schrumpf, Morten H. Vatn, L. S. Semb	9
20	Effect of Gastric Distention on Motility and Plasma Gastrin Concentration before and after Secretin Administration 1974 ·Scandinavian Journal of Gastroenterology ·E. Schrumpf, J. O. Stadaas	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact